SARAH ORDOYNE: Open Payments
NPI 1700431616 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 81 payments from 31 companies in 2025. Trend: 2023 $1,597 · 2024 $1,322 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $218 |
| Merck Sharp & Dohme LLC | 8 | $218 |
| Novartis Pharmaceuticals Corporation | 9 | $184 |
| ABBVIE INC. | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 5 | $122 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $109 |
| Genentech USA, Inc. | 3 | $88 |
| Celgene Corporation | 2 | $58 |
| Syndax Pharmaceuticals, Inc. | 2 | $55 |
Products named: KEYTRUDA, KISQALI, RYBREVANT, Nubeqa, Enhertu, OPDIVO, IMBRUVICA, EPKINLY.
Industry payments across LA — which companies pay providers there.
